Diagonal Bio Balance Sheet Health
Financial Health criteria checks 4/6
Diagonal Bio has a total shareholder equity of SEK26.9M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK29.4M and SEK2.5M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 1.73m |
| Equity | SEK 26.91m |
| Total liabilities | SEK 2.45m |
| Total assets | SEK 29.36m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DIABIO's short term assets (SEK4.5M) exceed its short term liabilities (SEK2.5M).
Long Term Liabilities: DIABIO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DIABIO is debt free.
Reducing Debt: DIABIO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DIABIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: DIABIO has less than a year of cash runway if free cash flow continues to grow at historical rates of 10.6% each year.